Myriad answers the most pressing questions for patients and their healthcare providers.
Because we believe every patient should be able to know their risk, their path, their plan and their choices regarding disease.
Myriad is the unquestioned industry leader in variant classification and reclassification. myVision™ is the most advanced program in the industry overseeing the classification and reclassification of uncertain variants and is part of Myriad’s commitment to patients and their families.
If there is any concern about affordability – no need to worry, we’ve secured great insurance coverage and have very accessible financial assistance programs in place to address your patient’s individual needs.
Advancing the Science
Myriad is dedicated, above all else, to improving patient care through pioneering research and the development of innovative molecular diagnostic tests.
Patient Support & Testing
Myriad is always working to advance the science of biotechnology through our patnerships and professional collaborations
Variants Classified in 2016
Variants Re-classified in 2016
Amended Reports Issued in 2016
BROAD INSURANCE COVERAGE
97% of private insurance companies are contracted with Myriad. As a result, the average out-of-pocket bill for patients tested at Myriad is $54, and 3 out of 4 patients have no out-of-pocket expense for their testing.
MYRIAD FINANCIAL ASSISTANCE PROGRAMS
If your patients have high deductible plans or high co-insurance, they may qualify for an out-of-pocket cost of no more than $100.
EXPLANATION OF BENEFITS
EOBs shouldn’t be a concern as they do not represent an amount due to Myriad, but we encourage patients to give us a call if they have any questions about their EOB.
with in-network providers – 95% of payers with Myriad are in-network
In hereditary cancer tests performed – more than 2.5 million with unmatched reputation for quality
Amount provided to support patient advocacy groups over the past 5 years for patient financial assistance and academic scholarships
Scientific publications consisting of clinically meaningful information have been published in peer reviewed journals over the past 5 years
Invested in research over the past 5 years